Figure 8 from Dominant Role of CD80–CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LATY136F CD4+ T Cells | Semantic Scholar
CD80 - an overview | ScienceDirect Topics
CD Antigens Related to Cell Activation | Sino Biological
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19 | Scientific Reports
2 CD80/CD86 deliver bidirectional signaling for the activation of T... | Download Scientific Diagram
Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma | Canadian Journal of Neurological Sciences | Cambridge Core
What's the difference between CD80 and CD86?: Trends in Immunology
CD28 is constitutively expressed on T cells and CD86 is expressed on... | Download Scientific Diagram
Frontiers | The Association Between CTLA-4, CD80/86, and CD28 Gene Polymorphisms and Rheumatoid Arthritis: An Original Study and Meta-Analysis
CD80 (B7.1) and CD86 (B7.2) induce EBV-transformed B cell apoptosis through the Fas/FasL pathway
The expression of CD80 and CD86 on either physiological or tumor-activated NK cells.
CD80 and CD86 knockdown in dendritic cells regulates Th1/Th2 cytokine production in asthmatic mice
T-cell Activation: The Purpose of CD28, CTLA-4, and CD80/CD86 | ProSci Incorporated
JCI - Human regulatory B cells in health and disease: therapeutic potential
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells | PNAS
b: T-cell activation is initiated by the interaction between CD28... | Download Scientific Diagram
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation | Nature Immunology
Frontiers | CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis
Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis | Genome Medicine | Full Text
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells | PNAS
Binding of CD80/CD86 and cytotoxic T-lymphocyte-associated protein 4... | Download Scientific Diagram
CD80+ and CD86+B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis | Journal of Neuroinflammation | Full Text
This study identified key differences in transendocytosis by CTLA-4 when activated by CD80 and CD86 ligands; whereby CD80 binding led to targeted ubiquitination and lysosomal degradation while CD86 binding led to enhanced
Figure 1
Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis | bioRxiv
Trogocytosis of CD80 and CD86 by induced regulatory T cells | Cellular & Molecular Immunology
